Kevin Ciabattoni

Kevin Ciabattoni brings to our firm over a decade of sell-side equity research experience on Wall Street covering sectors including health care, aerospace & defense, software, telecom, and business services. He joined Bertner Advisors after seven years at KeyBanc Capital Markets and previously spent four years at Boenning & Scattergood, Inc. He began his career as a software engineer and worked for companies including GMAC Mortgage and Standard & Poor’s prior to his transition to Wall Street. 

Kevin received his MBA with a concentration in Finance from the Fox School of Business at Temple University and a BA in Computer Science from Boston College.   

Greg Fraser

Greg Fraser brings to our firm over 15 years of experience as a sell-side equity research analyst covering the Specialty and U.S. Major Pharmaceuticals sectors. He joined Bertner Advisors after four years in equity research at Truist Securities; prior to Truist, Greg was a member of highly ranked analyst teams at Deutsche Bank and Bank of America Merrill Lynch. He began his professional career in health care investment banking at CIBC World Markets.

Greg received his MD and BS in Chemical Engineering from the University of Virginia.

Gerard Campagna has over a decade of experience in investment research covering the health care space, including on both the buy and sell-side.  He joined Bertner Advisors from Integral Health Asset Management, a long/short health care-dedicated hedge fund, where he served as a Senior Analyst contributing alpha-generating investment recommendations.  Prior to Integral Health, Gerard was a sell-side Research Associate at Stephens, Deutsche Bank, and Credit Suisse.  Gerard began his career at Bloomberg LP.  Gerard received both his MS in Business Intelligence and BS in Finance from Saint Joseph’s University.